U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT04260607) titled 'Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department' on Feb. 5.
Brief Summary: Current treatment for acutely suicidal patients are limited to hospitalization, psychotherapy, electro-convulsant therapy, or a combination of the aforementioned. However, this has added to the national boarding problem. Long term pharmacologic treatment for suicidal behaviors and mood stabilization has been studied in specific populations. In these populations, the decreases in suicidal ideation results from stabilization of the underlying psychiatric illness. Ketamine is most commonly used as an anesthetic with analgesic propert...